Research Grants show all

NIH1

Publications show all

ARCA Biopharma has published 1 articles.

Patents show all

495Applications150Issued

Clinical Trials show all

6Phase 24Phase 31Phase 1/Phase 2

SEC Filings show all

8-K23610-Q5910-K17D8S-11

Private Funding Events

DateOfferedSoldType
2014-02-20$326,158$326,158Option to Acquire, Security to be Acquired
2013-06-17$1,250,000$1,250,000Option to Acquire, Security to be Acquired
2013-02-01$1,000,000$1,000,000Equity, Option to Acquire, Security to be Acquired
2012-12-28$250,000$250,000Equity, Option to Acquire, Security to be Acquired
2012-10-31$325,000$325,000Equity, Option to Acquire, Security to be Acquired
2012-01-05$4,549,285$4,549,285Equity, Option to Acquire, Security to be Acquired
2009-10-26$499,999$499,999Equity, Option to Acquire, Security to be Acquired

Key Executives

  • Michael R. Bristow
    Executive Officer, Director
  • Kathryn E. Falberg
    Executive Officer
  • Christopher D. Ozeroff
    Executive Officer
  • Richard B. Brewer
    Director
  • Jean-Francois Formela
    Director
  • J. William Freytag
    Director
  • Linda Grais
    Director
  • Ted W. Love
    Director
  • Mary K. Pendergast
    Director
  • Burton E. Sobel
    Director
  • John L. Zabriskie
    Director
  • Patrick M. Wheeler
    Executive Officer
  • Robert E. Conway
    Director
  • Linda S. Grais
    Director
  • Raymond L. Woosley
    Director